Author:
Dou Peipei,Zhao Hengliang,Zhong Dan,Hu Yingliang,Liu Bin,Zhang Haiyan,Cao Aihong
Abstract
AbstractThis study aimed to optimize slope and energy levels for evaluating Ki-67 expression in lung cancer using virtual monoenergetic imaging and compare the predictive efficiency of different energy spectrum slopes (λHU) for Ki-67. Forty-three patients with primary lung cancer confirmed via pathological examination were enrolled in this study. They underwent baseline arterial-phase (AP) and venous-phase (VP) energy spectrum computed tomography (CT) scanning before surgery. The CT values were 40–190 keV, with 40–140 keV indicating pulmonary lesions at AP and VP, and P < 0.05 indicating a statistically significant difference. An immunohistochemical examination was conducted, and receiver operating characteristic curves were used to analyze the prediction performance of λHU for Ki-67 expression. SPSS Statistics 22.0 (IBM Corp., NY, USA) was used for statistical analysis, and χ2, t, and Mann–Whitney U tests were used for quantitative and qualitative analyses of data. Significant differences were observed at the corresponding CT values of 40 keV (as 40-keV is considered the best for single-energy image for evaluating Ki-67 expression) and 50 keV in AP and at 40, 60, and 70 keV in VP between high- and low-Ki-67 expression groups (P < 0.05). In addition, the λHU values of three-segment energy spectrum curve in both AP and VP were quite different between two groups (P < 0.05). However, the VP data had greater predictive values for Ki-67. The areas under the curve were 0.859, 0.856, and 0.859, respectively. The 40-keV single-energy sequence was the best single-energy sequence to evaluate the expression of Ki-67 in lung cancer and to obtain λHU values using the energy spectrum curve in the VP. The CT values had better diagnostic efficiency.
Funder
Medical Science and Technology Innovation Project of the Xuzhou Municipal Health Commission
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Sung, H., Ferlay, J., Siegel, R.L., et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA, 2021, 71(3): 209–249. https://doi.org/10.3322/caac.21660.
2. Radu, T.G., Mogoantă, L., Busuioc, C. J., et al. Histological and immunohistochemical aspects of papillary thyroid cancer. Roman. J. Morphol. Embryol. 2015, 56(2): 789–795.
3. Li, L, Jiang, G., Chen, Q., et al. Ki67 is a promising molecular target in the diagnosis of cancer (Review). Mol. Med. Rep., 2014.
4. Lin, L. et al. The associations among quantitative spectral CT parameters, Ki-67 expression levels and EGFR mutation status in NSCLC. Sci Rep 10(1), 3436. https://doi.org/10.1038/s41598-020-60445-0 (2020).
5. Visapää, H. et al. Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma. Urology. 42(12), 2933–2939 (2017).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献